IL6 and hepatocellular carcinoma: The HCC timepoint was characterized by a significant increase in interferon-gamma (IFN-γ), tumour necrosis factor alpha (TNF-α), IL-6 and IL-17 compared to inflammation and cirrhosis timepoints (all P < 0.05) (Fig. 5b-e).